Dev-Res-Prog-001

胶质瘤孢子发育研究计划（DRP）的目标是确定创新的试点 神经胶质瘤的研究项目，具有转化潜力。DRP采用征求和审查程序 选择有价值的试验计划，以获得资助。招标过程利用了一个既定的、广泛的 丹娜-法伯/哈佛癌症中心（DF/HCC）的通信基础设施，以广泛传播年度 征求建议书（RFP）。审查过程利用了一组经验丰富的DF/HCC胶质瘤科学家。 DRP为具有最终转化潜力的创新项目提供有限期限的资金， 可以与现有的SPORE项目和核心协同工作。DF/HCC机构从这一点匹配DRP资金 SPORE以扩大DRP获奖者的人数。DRP应用程序被判断为潜在的试点或 合作研究，将产生可行性数据，并为他们的最终潜力，成为完整的项目 在未来几年的SPORE计划中。DRP采用监控流程来衡量进度， DRP项目的成果，包括可能将成功的DRP奖励提升为完整项目。的 通过明确建立的指标和DRP奖的监督，对该计划进行密切监控 以马克思DRP获奖者必须提交半年进度报告。

The objective of the Glioma SPORE Developmental Research Program (DRP) is to identify innovative pilot research projects in glioma that have translational potential. The DRP utilizes a solicitation and review process to select meritorious pilot projects for funding. The solicitation process capitalizes on an established, extensive Dana-Farber/Harvard Cancer Center (DF/HCC) communications infrastructure to widely disseminate an annual Request for Proposals (RFP). The review process utilizes an experienced panel of DF/HCC glioma scientists. The DRP provides limited-duration funding for innovative projects that have ultimate translational potential and could synergize with existing SPORE projects and cores. DF/HCC institutions match DRP funding from this SPORE to expand the pool of DRP awardees. The DRP applications are judged for their potential as pilot or collaborative studies that will generate feasibility data and for their ultimate potential to emerge as full projects in future years of the SPORE program. The DRP employs a monitoring process to measure progress and outcomes of DRP projects including the possible elevation of successful DRP awards to full projects. The program is closely monitored through clearly established metrics and oversight by the DRP Awards Committee. DRP awardees are required to present biannual progress reports.